Australian Company, Care A2 Plus Pty Ltd Partners with US Pharmaceutical, Gensco® Pharma
Retrieved on:
Thursday, February 2, 2023
Caregiver, Science, Formula, Pharma, Breast milk, Criticism of the Food and Drug Administration, Woolworths Supermarkets, TerryWhite Chemmart, Infant, Medication, Nutrient, Food, Health, GMO, Parent, Absorption, Immune system, Lactoferrin, Partnership, FDA, Care, Infant formula, Supermarket, Kangaroo care, Dietary supplement, Pharmaceutical industry
DORAL, Fla., Feb. 2, 2023 /PRNewswire/ -- Amid a continuing supply chain crisis in the U.S. baby formula market, Australian health and wellness company, Care A2 Plus Pty Ltd ('Care'), and American Pharmaceutical Company, Gensco® Pharma, have announced a partnership to bring the already established Australian Infant formula into millions of American homes.
Key Points:
- DORAL, Fla., Feb. 2, 2023 /PRNewswire/ -- Amid a continuing supply chain crisis in the U.S. baby formula market, Australian health and wellness company, Care A2 Plus Pty Ltd ('Care'), and American Pharmaceutical Company, Gensco® Pharma, have announced a partnership to bring the already established Australian Infant formula into millions of American homes.
- The Food and Drug Administration the U.S., certifying that the Australian-made Care A2+ Infant Formula meets the standards set by the FDA.
- In early January 2023 the FDA extended the approval for Care A2+ to be sold in the US to October 2025.
- Care A2+ is sold through major Australian retailers Woolworths Supermarkets and major Pharmaceutical outlets - Chemist Warehouse and Terry White Chemists.